Browse All Providers

Find a Provider Near You

Find A Provider
Browse All Specialties

Learn more about a specialty

Find A Specialty
Accepted Insurance

Check to see if your insurance plan is accepted by CU Medicine Clinics.

Check for Insurance

Practice Locations

University of Colorado Cancer Center
CU Anschutz Medical Campus
1665 Aurora Ct Aurora, CO 80045

720-848-0300

Anosheh Afghahi, MD

Medical Oncology

Board Certified

Schedule Appointment

  • Gender

    Female

  • Department

    Assistant Clinical Professor, Medicine-Medical Oncology

  • Specialty

    Medical Oncology

  • Primary Clinic Phone

    720-848-2200

  • Hospital Affiliations

    University of Colorado Hospital
Print Share

Referring Provider Info

Locations

Practice Locations

UCHealth Lone Tree Medical Center
9548 Park Meadows Drive
Lone Tree, CO 80124

720-848-2200

Get directions

University of Colorado Cancer Center
CU Anschutz Medical Campus
1665 Aurora Ct
Aurora, CO 80045

720-848-0300

Get directions

UCHealth Diane O'Connor Thompson Breast Center - Anschutz
1635 Aurora Ct, 3rd Floor
Aurora, CO 80045

720-848-1030

Get directions

Provider Expertise

Clinical Interest for Patients

My clinical interest includes caring for patients and families with a personal or family history of breast and ovarian cancer.


Specialties

  • Medical Oncology

Conditions & Treatments

  • Cancers

    Breast Cancer

  • Genetic Conditions and Testing

Education & Training

Medical Schools

MD, Harvard Medical School (2009)


Graduate Schools

MPH, Harvard School of Public Health (2009)


Internships

Stanford Hospital and Clinics Program (2010)


Residency Program

Stanford Hospital and Clinics Program (2012)


Fellowships

Stanford Hospital and Clinics Program (2015)

information for referring providers

Referral Contact Phone

720-848-2200

Referral Contact Fax

720-553-0901

Referring Patients Link

Information for Referring and Transferring Patients

Clinical Interests for Referring Providers

My clinical and research focus is hereditary and triple-negative breast cancer. I conduct a combination of population-based, translational and clinical research studies.